Legal Advantage Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Hold
2,783
0.35% 50
2026
Q1
$979K Sell
2,783
-100
-3% -$35.6K 0.51% 49
2025
Q4
$944K Hold
2,883
0.44% 55
2025
Q3
$814K Hold
2,883
0.37% 60
2025
Q2
$805K Sell
2,883
-225
-7% -$63.7K 0.38% 60
2025
Q1
$968K Hold
3,108
0.52% 51
2024
Q4
$810K Sell
3,108
-22
-0.7% -$6.53K 0.43% 54
2024
Q3
$1.01M Buy
3,130
+1,000
+47% +$327K 0.55% 52
2024
Q2
$666K Buy
2,130
+5
+0.2% +$1.47K 0.38% 60
2024
Q1
$604K Buy
2,125
+525
+33% +$154K 0.34% 67
2023
Q4
$461K Buy
+1,600
New +$436K 0.28% 72

Other funds holding AMGN

Legal Advantage Investments's AMGN Position: Q2 2026 in Review

Legal Advantage Investments held its Amgen (AMGN) position steady in Q2 2026 at 2,783 shares worth $1.01M. The position accounts for 0.35% of the portfolio, ranked #50.

Legal Advantage Investments first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.01M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Legal Advantage Investments held 2,783 shares of Amgen worth $1.01M as of Q2 2026.
  • Legal Advantage Investments left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.35% of Legal Advantage Investments's portfolio in Q2 2026, its #50 holding.
  • Legal Advantage Investments first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Legal Advantage Investments's Amgen position peaked at $1.01M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.